VCIM
CRBP icon

Velan Capital Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Velan Capital Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Hold
26,000
– – 0.15% 33
2026
Q1 		$244K Buy
26,000
+13,000
+100% +$109K 0.15% 34
2025
Q4 		$106K Sell
13,000
-48,000
-79% -$592K 0.06% 42
2025
Q3 		$772K Buy
61,000
+2,000
+3% +$19K 0.72% 24
2025
Q2 		$407K Hold
59,000
– – 0.4% 27
2025
Q1 		$313K Buy
59,000
+2,300
+4% +$20.3K 0.32% 28
2024
Q4 		$669K Buy
56,700
+6,700
+13% +$112K 0.58% 19
2024
Q3 		$1.03M Buy
+50,000
New +$2.56M 0.96% 15

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Velan Capital Investment Management's CRBP Position: Q2 2026 in Review

Velan Capital Investment Management held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 26,000 shares worth $244K. The position accounts for 0.15% of the portfolio, ranked #33.

Velan Capital Investment Management first reported a position in CRBP in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.03M in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Velan Capital Investment Management held 26,000 shares of Corbus Pharmaceuticals worth $244K as of Q2 2026.
  • Velan Capital Investment Management left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up 0.15% of Velan Capital Investment Management's portfolio in Q2 2026, its #33 holding.
  • Velan Capital Investment Management first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Velan Capital Investment Management's Corbus Pharmaceuticals position peaked at $1.03M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.